This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Drug Delivery Solutions Market

Drug Delivery Solutions Market By Product Type (Bottles, Vials & Ampoules, Blisters, Bags & Pouches, Prefilled Syringes & Cartridges, Sachets, Trays, Tubes, Caps & Closures, Container, Jars), Material (Plastics, Glass, Metals, Paper) & Region - Forecast 2021 - 2031

Market Insights on Drug Delivery Solutions covering sales outlook, demand forecast & up-to-date key trends

Drug Delivery Solutions Market Outlook – 2021-2031

[275 pages Report] The global drug delivery solutions market size was valued at US$ 94.3 Bn in 2021 and is projected to reach US$ 181.9 Bn by the end of 2031, exhibiting growth at 6.8% CAGR between 2021 and 2031.

Drug Delivery Solutions Market Size 2021

US$ 94.3 Bn

Drug Delivery Solutions Market Size 2031

US$ 181.9 Bn

Value CAGR (2021-2031)

6.8%

Collective Value Share: Top 3 Countries (2021E)

33%

Regionally, South Asia is expected to dominate the drug delivery solutions market. In 2021, the drug delivery solutions market in India grew by 10.6% year-over-year (y-o-y), amid growing demand for drug delivery solution, following the outbreak of COVID-19.

Across South Asia, total sales of drug delivery solutions are estimated to reach US$ 33.2 Bn in 2031.

2015-2020 Drug Delivery Solutions Market Outlook Compared to 2021-2031 Forecast

Future Market Insights has predicted the global drug delivery solutions market to rise at 6.8% CAGR from 2021 to 2031 in comparison to the 5.1% CAGR registered during 2015 to 2020. As per the study, the drug delivery solutions market is expected to hold almost about 5.8% of the healthcare industry.

Rising popularity of biological drug medications is expected to create new tailwinds for the demand in the market. These new medications are unique in relation to small molecule formulations, as a result, demand for new formats and materials is surging.

In terms of material, the glass vial packaging format is gaining immense popularity, propelling the demand in the market. Some novel biologics have properties that delaminate glass, prompting undesirable glass chipping in formulations.

Hence, key manufacturers are developing vials that are resistant to harsh temperature and improved in heating procedure so that chipping can be alleviated. Thus, new biological drug formulations are driving the demand for new packaging formats.

Drug Delivery Solutions Market Report Brochure

Regionally, Europe pharmaceutical packaging market is witnessing a growing trend of advanced design and technological features being incorporated in packaging products.

Conventional and widely used pharmaceutical packaging solutions such as blister packs and pharmaceutical bottles are incorporated with digital technology that features advanced functionality for end-user and patients.

Customize this Report

Let us know your requirement to get
100% FREE customization

Preference for Disposable Packaging Fuelling Demand for Drug Delivery Solutions

Conventional pharmaceutical packaging solutions include wraps and cotton among others. Advent of thermoformable materials enabled the usage of new packaging solutions such as thermoformed trays and blister packaging.

Consequently, growing demand for good lidding materials encouraged the manufacturers of pharmaceutical packaging solutions to come up with new packaging solutions with improved film laminations, increasing the adoption of thermoplastic polymers.

As the quality of healthcare continues to improve across the globe, it is anticipated that the global pharmaceutical packaging market will benefit from the surging demand for newer drug delivery solutions.

How is Demand for Flexible Packaging Solutions Affecting Drug Delivery Solutions Companies?

Rigid packaging products, traditionally preferred in the pharmaceutical industry, are rapidly being replaced by flexible packaging products made of plastics. Growing preference for flexible packaging and particularly for high-performance applications, is expected to generate new opportunities for packaging barrier films.

Steered by its lightweight, flexible, and durable properties flexible plastics, are increasingly replacing rigid packaging made of rigid plastics and other non-plastic materials (including glass and metal).

Glass and metal materials, which are prominently used in rigid packaging, offer high barrier packaging irrespective of shelf-life requirements. Furthermore, rigid packaging formats are vulnerable to breakage and corrosion.

Hence, brands are introducing new flexible packaging solutions, which can provide longer shelf life and convenient user experience. Plastic flexible packaging products can be made in opaque as well as transparent forms depending upon the merchandising requirements of products.

Thus, flexible packaging products are made of plastics which allow product manufacturers and brands the ability to enhance product appeal through innovative packaging designs.

Ismail Sutaria
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Insights

How Will Expansion of India’s Healthcare Industry Impact the Demand for Drug Delivery Solutions?

“Favorable Norms for Packaging Solution to Boost Drug Delivery Solutions Demand”

India is expected to be the largest shareholder, contributing over 41% in the South Asia drug delivery solutions market by the end of 2031. Penetration of the advance healthcare facilities and cost-effective manufacturing will create conducive environment for drug delivery solutions market in India.

According to National Health Mission, the Government of India is investing extensively to upgrade existing hospitals and develop improved healthcare infrastructure, with modern pharmaceutical packaging and facilities.

This has led to an increasing demand for safe and efficient packaging solutions for pharmaceutical products in the country. Besides this, increasing production of healthcare products by India is increasing the demand for drug delivery solutions.

As per the study, consumption of sustainable and recyclable delivery solutions has increased due to high expenditure on healthcare industry, propelling the demand in India drug delivery solutions market.

Will the Demand for Drug Delivery Solutions Increase in Japan?

“Growing Sustainability Concerns to Create Growth Opportunities for Japan Drug Delivery Solutions Market”

Future Market Insights opines, Japan is one of the key producers of drug delivery solutions in East-Asia, surpassing US$ 11.9 Bn by the end of 2031. Key players in Japan are majorly focused on developing a safe product for end users.

Also, healthcare equipment service providers from Japan are undergoing a transition towards plastic delivery solutions. As these solutions are sustainable, adoption of these solutions is increasing to reduce carbon footprint.

Subsequently, the Japan drug delivery solutions market will create an incremental opportunity of US$ 7.2 Bn between 2021 and 2031.

Category-wise Insights

Why are Bottles More Preferred as Drug Delivery Solutions?

“Bottles to Remain Highly Sought-After Packaging Format for Drug Delivery Solutions”

Bottles are widely used in healthcare sector due to the convenience in packaging. As per FMI, this segment accounted for over 40% of global market share in 2020. With increasing demand for medicines and drugs, bottles are more preferred as a safe packaging solution.

Properties such as ease in storage and handling, ease in usage is mostly affecting the use of bottles for drug delivery solutions and packaging. Due to this people are more inclined towards purchasing bottles.

As a result, the usage of bottles in drug delivery solutions will expand by 1.7x and expected to lose -490 BPS by the end of 2031. 

Which is the Chief Application in Drug Delivery Solutions Market?

“Demand for Injectable Drug Delivery Solutions to Outpace the Others”

In terms of application, injectable segment will lead the application segment in global drug delivery solutions. The segment held a market share of about 36% in the year 2020, estimates FMI.

Injectable segment will continue to lead the application segment of the target market due to high demand of easy to use and disposable drug delivery solutions.

However, pulmonary and nasal segments will witness significant growth, recording incremental opportunity of US$ 16.2 Bn and US$ 12.8 Bn, respectively between 2021 and 2031.

In emerging economies, government expenditure on healthcare facilities has abruptly rose in the last decade, and the injectable segment is expected to increase by 1.9x in 2021.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

Companies operating in the drug delivery solutions market are aiming at expansions and strategic partnerships with other manufacturers to expand their product manufacturing capabilities and strengthen their global footprints.

For instance,

  • In November 2021, Schott AG received funding from the German Federal Ministry for the Environment (BMU) to develop climate-friendly glass production and reduce carbon emissions.
  • Becton, Dickinson and Company, in November 2021, had the opening ceremony of its high-tech manufacturing facility in Zaragoza, Spain, for supporting the growth of pre-filled drug delivery systems.
  • In 2021, Gerresheimer AG announced a strategic partnership with Midas Pharma for the development and marketing of its own IP autoinjector.
  • In October 2021, West Pharmaceutical Services, Inc. launched a new Vialg2Bag Advanced 20 mm admixture device designed specially to maximize the benefits of point-of-care nursing.
  • In August 2021, Ardagh Group S.A. announced the complete acquisition of Gores Holdings V, Inc. under a special purpose acquisition agreement with The Gores Group.

Scope Of Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2015-2020

Market Analysis

US$ Million for Value, Mn Units for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia,  MEA, Oceania

Key Countries Covered

US, Canada, Brazil, Germany U.K., France, Italy, Spain, Russia,  China, Japan, South Korea, India, Australia, GCC Countries, and South Africa

Key Segments Covered

Product type, Material, Application and Region

Key Companies Profiled

  • Amcor Plc
  • SCHOTT AG
  • Gerresheimer AG
  • Berry Global Group Inc.
  • Mondi Plc
  • Sealed Air Corp.
  • Wipak Group
  • Constantia Flexibles
  • Ardagh Group SA
  • Sonoco Products Company
  • West Pharmaceuticals Services Inc.
  • WestRock Company
  • UFlex Ltd.
  • Parekhplast India Ltd.
  • Others

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Drug Delivery Solutions Market By Category

By Product Type:

  • Bottles
    • Packer Bottles
    • Liquid Bottles
  • Vials & Ampoules
  • Blisters
  • Bags & Pouches
  • Prefilled Syringes & Cartridges
  • Sachets
  • Trays
  • Tubes
  • Caps & Closures
  • Container, Jars & Others

By Material:

  • Plastics
    • PE
      • LDPE
      • HDPE
    • PVC
    • PP
    • PS
    • PET
    • Others
  • Glass
  • Metal
  • Paper

By Applications:

  • Nasal
  • Pulmonary
  • Injectable
  • Eye Care
  • Dermal/ Transdermal
  • Other Applications

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Middle East & Africa
  • Oceania

Frequently Asked Questions

Adoption of advanced technology for enhancing safety and temperature monitoring is improving the demand for drug delivery solutions.

High requirement of effective & sustainable drug delivery solutions in healthcare sector will drive the demand for the drug delivery solutions market.

Top five companies operating in the drug delivery solutions market are Johnson & Johnson, Roche Holding AG, Novartis AG, Merck & Co. Inc., and GSK Plc. These companies covered nearly 22% to 23% of the overall market in 2020.

FMI has anticipated that the Europe drug delivery solutions market will exhibit growth at a CAGR of 6.1% , surpassing US$ 19.9 Bn between 2021 and 2031.

As per FMI, Japan drug delivery solutions market is expected to rise at 8.6 % CAGR, expanding by 2.3x between 2021 and 2031.

Table of Content

1. Executive Summary

    1.1. Global Market Overview

    1.2. Market Analysis

    1.3. Analysis and Recommendations

    1.4. Global Market Overview

    1.5. Market Characteristics & Attributes

    1.6. Market Statistics

    1.7. Analysis and Recommendations

        1.7.1. Overall Market Approach

        1.7.2. Target Segment

        1.7.3. Target Region

        1.7.4. Differentiating Strategy

        1.7.5. Expected Barriers

2. Market Overview

    2.1. Market Definition

    2.2. Market Taxonomy 

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Product USPs / Features

5. Global Drug Delivery Solutions Market Demand Analysis 2015-2020 and Forecast, 2021-2031

    5.1. Historical Market Volume (Bn Units) Analysis, 2015-2020

    5.2. Current and Future Market Volume (Bn Units) Projections, 2021-2031

    5.3. Y-o-Y Growth Trend Analysis

6. Global Drug Delivery Solutions Market - Pricing Analysis

    6.1. Regional Pricing Analysis, by Product

    6.2. Pricing Break-up

    6.3. Global Average Pricing Analysis Benchmark

7. Global Drug Delivery Solutions Market Demand (US$ Mn) Analysis 2015-2020 and Forecast, 2021-2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Global Packaging Market Overview

    8.2. Global Plastic Packaging Market Overview

    8.3. Global Flexible Packaging Market Overview

    8.4. Global Rigid Packaging Market Outlook

    8.5. Global Pharmaceutical Industry Outlook

    8.6. Macro-Economic Factors & Co-relation Analysis

        8.6.1. Global GDP 

        8.6.2. GDP Per Capita

        8.6.3. Manufacturing Value Added

        8.6.4. Rigid Packaging Industry

        8.6.5. Packaging Industry

    8.7. Forecast Factors - Relevance & Impact

        8.7.1. GDP Growth

        8.7.2. Segmental Revenue Growth of Key Players

        8.7.3. Manufacturing Value Added Growth

        8.7.4. Rigid Packaging Industry Growth

        8.7.5. Packaging Industry Growth

    8.8.  Value Chain Analysis

        8.8.1. Key Market Participants

            8.8.1.1. Raw Material Suppliers

            8.8.1.2. Drug Delivery Solutions/Format Manufacturers

            8.8.1.3. End-users

        8.8.2. Profitability Margin

    8.9. Market Dynamics

        8.9.1. Drivers

        8.9.2. Restraints

        8.9.3. Opportunity Analysis

9. Impact of COVID-19

    9.1. Current Statistics and Probable Future Impact

    9.2. Impact of COVID-19 on Drug Delivery Solutions Market

10. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Product

    10.1. Introduction 

    10.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Product, 2015-2020

    10.3. Current and Future Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Product, 2021-2031

        10.3.1. Bottles

            10.3.1.1. Packer Bottles

            10.3.1.2. Liquid Bottles

        10.3.2. Vials & Ampoules

        10.3.3. Blisters

        10.3.4. Bags & Pouches

        10.3.5. Prefilled Syringes & Cartridges

        10.3.6. Sachets

        10.3.7. Trays

        10.3.8. Tubes

        10.3.9. Caps & Closures

        10.3.10. Container, Jars & Others

    10.4. Market Attractiveness Analysis, by Product 

11. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, By Material

    11.1. Introduction 

    11.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Material, 2015-2020

    11.3. Current and Future Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Material, 2021-2031

        11.3.1. Plastics

            11.3.1.1. PE

                11.3.1.1.1. LDPE

                11.3.1.1.2. HDPE

            11.3.1.2. PVC

            11.3.1.3. PP

            11.3.1.4. PS

            11.3.1.5. PET

            11.3.1.6. Others 

        11.3.2. Glass

        11.3.3. Metals

        11.3.4. Paper

    11.4. Market Attractiveness Analysis, by Material

12. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Application

    12.1. Introduction 

    12.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Application, 2015-2020

    12.3. Current and Future Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Application, 2021-2031

        12.3.1. Nasal

        12.3.2. Pulmonary

        12.3.3. Injectable

        12.3.4. Eye Care

        12.3.5. Dermal/Transdermal

        12.3.6. Other Applications 

    12.4. Market Attractiveness Analysis, by Application

13. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Region, 2015-2020

    13.3. Current Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Region, 2021-2031

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia 

        13.3.5. East Asia

        13.3.6. Middle East and Africa (MEA)

        13.3.7. Oceania

    13.4. Market Attractiveness Analysis, by Region

14. North America Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020

    14.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031

        14.3.1.  By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Product

        14.3.3. By Material

        14.3.4. By Applications

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By Material

        14.4.4. By Applications

    14.5. Key Market Participants - Intensity Mapping

15. Latin America Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020

    15.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031

        15.3.1.  By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product

        15.3.3. By Material

        15.3.4. By Applications

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Material

        15.4.4. By Applications

    15.5. Key Market Participants - Intensity Mapping

16. Europe Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020

    16.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031

        16.3.1.  By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Nordics

            16.3.1.8. Russia

            16.3.1.9. Poland

            16.3.1.10. Rest of Europe

        16.3.2. By Product

        16.3.3. By Material

        16.3.4. By Applications

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By Material

        16.4.4. By Applications

    16.5. Key Market Participants - Intensity Mapping

17. South Asia Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020

    17.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031

        17.3.1.  By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Product

        17.3.3. By Material

        17.3.4. By Applications

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By Material

        17.4.4. By Applications

    17.5. Key Market Participants - Intensity Mapping

18. East Asia Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020

    18.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031

        18.3.1.  By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

            18.3.1.4. Rest of East Asia

        18.3.2. By Product

        18.3.3. By Material

        18.3.4. By Applications

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By Material

        18.4.4. By Applications

    18.5. Key Market Participants - Intensity Mapping

    18.6. 

19. Oceania Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020

    19.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031

        19.3.1.  By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product

        19.3.3. By Material

        19.3.4. By Applications

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By Material

        19.4.4. By Applications

    19.5. Key Market Participants - Intensity Mapping

20. Middle East and Africa Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020

    20.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031

        20.3.1.  By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. Northern Africa

            20.3.1.4. South Africa

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Product

        20.3.3. By Material

        20.3.4. By Applications

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Product

        20.4.3. By Material

        20.4.4. By Applications

    20.5. Key Market Participants - Intensity Mapping

21. Drug Delivery Solutions Market Country-wise Analysis and Forecast 

    21.1. U.S. Drug Delivery Solutions Market Analysis 2021 & 2031

        21.1.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.1.1.1. By Product

            21.1.1.2. By Material

            21.1.1.3. By Applications

    21.2. Canada Drug Delivery Solutions Market Analysis 2021 & 2031

        21.2.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.2.1.1. By Product

            21.2.1.2. By Material

            21.2.1.3. By Applications

    21.3. Brazil Drug Delivery Solutions Market Analysis 2021 & 2031

        21.3.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.3.1.1. By Product

            21.3.1.2. By Material

            21.3.1.3. By Applications

    21.4. Mexico Drug Delivery Solutions Market Analysis 2021 & 2031

        21.4.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.4.1.1. By Product

            21.4.1.2. By Material

            21.4.1.3. By Applications

    21.5. Germany Drug Delivery Solutions Market Analysis 2021 & 2031

        21.5.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.5.1.1. By Product

            21.5.1.2. By Material

            21.5.1.3. By Applications

    21.6. Italy Drug Delivery Solutions Market Analysis 2021 & 2031

        21.6.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.6.1.1. By Product

            21.6.1.2. By Material

            21.6.1.3. By Applications

    21.7. France Drug Delivery Solutions Market Analysis 2021 & 2031

        21.7.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.7.1.1. By Product

            21.7.1.2. By Material

            21.7.1.3. By Applications

    21.8. U.K. Drug Delivery Solutions Market Analysis 2021 & 2031

        21.8.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.8.1.1. By Product

            21.8.1.2. By Material

            21.8.1.3. By Applications

    21.9. Spain Drug Delivery Solutions Market Analysis 2021 & 2031

        21.9.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.9.1.1. By Product

            21.9.1.2. By Material

            21.9.1.3. By Applications

    21.10. Russia Drug Delivery Solutions Market Analysis 2021 & 2031

        21.10.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.10.1.1. By Product

            21.10.1.2. By Material

            21.10.1.3. By Applications

    21.11. GCC Countries Drug Delivery Solutions Market Analysis 2021 & 2031

        21.11.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.11.1.1. By Product

            21.11.1.2. By Material

            21.11.1.3. By Applications

    21.12. China Drug Delivery Solutions Market Analysis 2021 & 2031

        21.12.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.12.1.1. By Product

            21.12.1.2. By Material

            21.12.1.3. By Applications

    21.13. Japan Drug Delivery Solutions Market Analysis 2021 & 2031

        21.13.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.13.1.1. By Product

            21.13.1.2. By Material

    21.14. India Drug Delivery Solutions Market Analysis 2021 & 2031

        21.14.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.14.1.1. By Product

            21.14.1.2. By Material

    21.15. Australia Drug Delivery Solutions Market Analysis 2021 & 2031

        21.15.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy

            21.15.1.1. By Product

            21.15.1.2. By Material

            21.15.1.3. By Applications

22. Market Structure Analysis

    22.1. Market Analysis, by Tier of Drug Delivery Solutions Companies 

    22.2. Market Share Analysis of Top Players

    22.3. Market Presence Analysis

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Customer Deep Dive

        23.3.1. Drug Manufacturers

(Key Customers)

            23.3.1.1. Pfizer Inc.

            23.3.1.2. GlaxoSmithKline (GSK) plc.

            23.3.1.3. Sanofi

            23.3.1.4. Roche Holding AG

            23.3.1.5. Novartis AG

            23.3.1.6. Allergan (Abbvie Inc.)

            23.3.1.7. Johnson & Johnson

            23.3.1.8. Merck & Co., Inc.

            23.3.1.9. Sun Pharmaceutical Industries Ltd.

            23.3.1.10. Cadila Healthcare

        23.3.2. Drug Delivery Solutions Manufacturers

(Key Global Market Players)

        23.3.3. Amcor Plc

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Profitability by Market Segments

            23.3.3.4. Sales Footprint

            23.3.3.5. Strategy Overview

                23.3.3.5.1. Marketing Strategy

                23.3.3.5.2. Product Strategy

                23.3.3.5.3. Channel Strategy

        23.3.4. Schott AG

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Profitability by Market Segments

            23.3.4.4. Sales Footprint

            23.3.4.5. Strategy Overview

                23.3.4.5.1. Marketing Strategy

                23.3.4.5.2. Product Strategy

                23.3.4.5.3. Channel Strategy

        23.3.5. Gerresheimer AG

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Profitability by Market Segments

            23.3.5.4. Sales Footprint

            23.3.5.5. Strategy Overview

                23.3.5.5.1. Marketing Strategy

                23.3.5.5.2. Product Strategy

                23.3.5.5.3. Channel Strategy

        23.3.6. Berry Global, Inc.

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Profitability by Market Segments

            23.3.6.4. Sales Footprint

            23.3.6.5. Strategy Overview

                23.3.6.5.1. Marketing Strategy

                23.3.6.5.2. Product Strategy

                23.3.6.5.3. Channel Strategy

        23.3.7. Klockner Pentaplast Group

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Profitability by Market Segments

            23.3.7.4. Sales Footprint

            23.3.7.5. Strategy Overview

                23.3.7.5.1. Marketing Strategy

                23.3.7.5.2. Product Strategy

                23.3.7.5.3. Channel Strategy

        23.3.8. Becton, Dickinson and Company

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Profitability by Market Segments

            23.3.8.4. Sales Footprint

            23.3.8.5. Strategy Overview

                23.3.8.5.1. Marketing Strategy

                23.3.8.5.2. Product Strategy

                23.3.8.5.3. Channel Strategy

        23.3.9. Ardagh Group S.A.

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Profitability by Market Segments

            23.3.9.4. Sales Footprint

            23.3.9.5. Strategy Overview

                23.3.9.5.1. Marketing Strategy

                23.3.9.5.2. Product Strategy

                23.3.9.5.3. Channel Strategy

        23.3.10. West Pharmaceutical Service, Inc.

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Profitability by Market Segments

            23.3.10.4. Sales Footprint

            23.3.10.5. Strategy Overview

                23.3.10.5.1. Marketing Strategy

                23.3.10.5.2. Product Strategy

                23.3.10.5.3. Channel Strategy

        23.3.11. Bilcare Limited

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Profitability by Market Segments

            23.3.11.4. Sales Footprint

            23.3.11.5. Strategy Overview

                23.3.11.5.1. Marketing Strategy

                23.3.11.5.2. Product Strategy

                23.3.11.5.3. Channel Strategy

        23.3.12. Wipak Group

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Profitability by Market Segments

            23.3.12.4. Sales Footprint

            23.3.12.5. Strategy Overview

                23.3.12.5.1. Marketing Strategy

                23.3.12.5.2. Product Strategy

                23.3.12.5.3. Channel Strategy

        23.3.13. Mondi Plc

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Profitability by Market Segments

            23.3.13.4. Sales Footprint

            23.3.13.5. Strategy Overview

                23.3.13.5.1. Marketing Strategy

                23.3.13.5.2. Product Strategy

                23.3.13.5.3. Channel Strategy

        23.3.14. Sealed Air Corporation

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Profitability by Market Segments

            23.3.14.4. Sales Footprint

            23.3.14.5. Strategy Overview

                23.3.14.5.1. Marketing Strategy

                23.3.14.5.2. Product Strategy

                23.3.14.5.3. Channel Strategy

        23.3.15. Constantia Flexibles

            23.3.15.1. Overview

            23.3.15.2. Product Portfolio

            23.3.15.3. Profitability by Market Segments

            23.3.15.4. Sales Footprint

            23.3.15.5. Strategy Overview

                23.3.15.5.1. Marketing Strategy

                23.3.15.5.2. Product Strategy

                23.3.15.5.3. Channel Strategy

        23.3.16. Clondalkin Group Holdings B.V.

            23.3.16.1. Overview

            23.3.16.2. Product Portfolio

            23.3.16.3. Profitability by Market Segments

            23.3.16.4. Sales Footprint

            23.3.16.5. Strategy Overview

                23.3.16.5.1. Marketing Strategy

                23.3.16.5.2. Product Strategy

                23.3.16.5.3. Channel Strategy

        23.3.17. West Rock Company

            23.3.17.1. Overview

            23.3.17.2. Product Portfolio

            23.3.17.3. Profitability by Market Segments

            23.3.17.4. Sales Footprint

            23.3.17.5. Strategy Overview

                23.3.17.5.1. Marketing Strategy

                23.3.17.5.2. Product Strategy

                23.3.17.5.3. Channel Strategy

        23.3.18. UDG Healthcare plc

            23.3.18.1. Overview

            23.3.18.2. Product Portfolio

            23.3.18.3. Profitability by Market Segments

            23.3.18.4. Sales Footprint

            23.3.18.5. Strategy Overview

                23.3.18.5.1. Marketing Strategy

                23.3.18.5.2. Product Strategy

                23.3.18.5.3. Channel Strategy

        23.3.19. Catalent, Inc.

            23.3.19.1. Overview

            23.3.19.2. Product Portfolio

            23.3.19.3. Profitability by Market Segments

            23.3.19.4. Sales Footprint

            23.3.19.5. Strategy Overview

                23.3.19.5.1. Marketing Strategy

                23.3.19.5.2. Product Strategy

                23.3.19.5.3. Channel Strategy

        23.3.20. Sonocco Products Company

            23.3.20.1. Overview

            23.3.20.2. Product Portfolio

            23.3.20.3. Profitability by Market Segments

            23.3.20.4. Sales Footprint

            23.3.20.5. Strategy Overview

                23.3.20.5.1. Marketing Strategy

                23.3.20.5.2. Product Strategy

                23.3.20.5.3. Channel Strategy

        23.3.21. Reike Corporation

            23.3.21.1. Overview

            23.3.21.2. Product Portfolio

            23.3.21.3. Profitability by Market Segments

            23.3.21.4. Sales Footprint

            23.3.21.5. Strategy Overview

                23.3.21.5.1. Marketing Strategy

                23.3.21.5.2. Product Strategy

                23.3.21.5.3. Channel Strategy

        23.3.22. Adelphi Healthcare Packaging

            23.3.22.1. Overview

            23.3.22.2. Product Portfolio

            23.3.22.3. Profitability by Market Segments

            23.3.22.4. Sales Footprint

            23.3.22.5. Strategy Overview

                23.3.22.5.1. Marketing Strategy

                23.3.22.5.2. Product Strategy

                23.3.22.5.3. Channel Strategy

(Asia Pacific based Key Market Players)

        23.3.23. Nipro Corporation

            23.3.23.1. Overview

            23.3.23.2. Product Portfolio

            23.3.23.3. Profitability by Market Segments

            23.3.23.4. Sales Footprint

            23.3.23.5. Strategy Overview

                23.3.23.5.1. Marketing Strategy

                23.3.23.5.2. Product Strategy

                23.3.23.5.3. Channel Strategy

        23.3.24. Uflex Ltd.

            23.3.24.1. Overview

            23.3.24.2. Product Portfolio

            23.3.24.3. Profitability by Market Segments

            23.3.24.4. Sales Footprint

            23.3.24.5. Strategy Overview

                23.3.24.5.1. Marketing Strategy

                23.3.24.5.2. Product Strategy

                23.3.24.5.3. Channel Strategy

        23.3.25. ACG Pharmapack Pvt. Ltd.

            23.3.25.1. Overview

            23.3.25.2. Product Portfolio

            23.3.25.3. Profitability by Market Segments

            23.3.25.4. Sales Footprint

            23.3.25.5. Strategy Overview

                23.3.25.5.1. Marketing Strategy

                23.3.25.5.2. Product Strategy

                23.3.25.5.3. Channel Strategy

        23.3.26. Piramal Glass Limited

            23.3.26.1. Overview

            23.3.26.2. Product Portfolio

            23.3.26.3. Profitability by Market Segments

            23.3.26.4. Sales Footprint

            23.3.26.5. Strategy Overview

                23.3.26.5.1. Marketing Strategy

                23.3.26.5.2. Product Strategy

                23.3.26.5.3. Channel Strategy

        23.3.27. Parekhplast India Ltd.

            23.3.27.1. Overview

            23.3.27.2. Product Portfolio

            23.3.27.3. Profitability by Market Segments

            23.3.27.4. Sales Footprint

            23.3.27.5. Strategy Overview

                23.3.27.5.1. Marketing Strategy

                23.3.27.5.2. Product Strategy

                23.3.27.5.3. Channel Strategy

        23.3.28. Shandong Pharmaceutical Glass Co., Ltd.

            23.3.28.1. Overview

            23.3.28.2. Product Portfolio

            23.3.28.3. Profitability by Market Segments

            23.3.28.4. Sales Footprint

            23.3.28.5. Strategy Overview

                23.3.28.5.1. Marketing Strategy

                23.3.28.5.2. Product Strategy

                23.3.28.5.3. Channel Strategy

        23.3.29. Avesta Continental Pack

            23.3.29.1. Overview

            23.3.29.2. Product Portfolio

            23.3.29.3. Profitability by Market Segments

            23.3.29.4. Sales Footprint

            23.3.29.5. Strategy Overview

                23.3.29.5.1. Marketing Strategy

                23.3.29.5.2. Product Strategy

                23.3.29.5.3. Channel Strategy

        23.3.30. Shanghai Tongpeng Electric Material Co., Ltd.

            23.3.30.1. Overview

            23.3.30.2. Product Portfolio

            23.3.30.3. Profitability by Market Segments

            23.3.30.4. Sales Footprint

            23.3.30.5. Strategy Overview

                23.3.30.5.1. Marketing Strategy

                23.3.30.5.2. Product Strategy

                23.3.30.5.3. Channel Strategy

        23.3.31. Khemka Glass

            23.3.31.1. Overview

            23.3.31.2. Product Portfolio

            23.3.31.3. Profitability by Market Segments

            23.3.31.4. Sales Footprint

            23.3.31.5. Strategy Overview

                23.3.31.5.1. Marketing Strategy

                23.3.31.5.2. Product Strategy

                23.3.31.5.3. Channel Strategy

        23.3.32. TPAC Packaging India Private Limited (Sunpet)

            23.3.32.1. Overview

            23.3.32.2. Product Portfolio

            23.3.32.3. Profitability by Market Segments

            23.3.32.4. Sales Footprint

            23.3.32.5. Strategy Overview

                23.3.32.5.1. Marketing Strategy

                23.3.32.5.2. Product Strategy

                23.3.32.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Product, 2015H-2031F

Table 02: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Product, 2015H-2031F

Table 03: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Material, 2015H-2031F

Table 04: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Material, 2015H-2031F

Table 05: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Applications, 2015H-2031F

Table 06: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Applications, 2015H-2031F

Table 07: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Region, 2015H-2031F

Table 08: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Region, 2015H-2031F

Table 09: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F

Table 10: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F

Table 11: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F

Table 12: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F

Table 13: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F

Table 14: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F

Table 15: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F

Table 16: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F

Table 17: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F

Table 18: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F

Table 19: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F

Table 20: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F

Table 21: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F

Table 22: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F

Table 23: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F

Table 24: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F

Table 25: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F

Table 26: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F

Table 27: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F

Table 28: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F

Table 29: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F

Table 30: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F

Table 31: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F

Table 32: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F

Table 33: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F

Table 34: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F

Table 35: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F

Table 36: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F

Table 37: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F

Table 38: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F

Table 39: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F

Table 40: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F

Table 41: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F

Table 42: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F

Table 43: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F

Table 44: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F

Table 45: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F

Table 46: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F

Table 47: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F

Table 48: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F

Table 49: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F

Table 50: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F

Table 51: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F

Table 52: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F

Table 53: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F

Table 54: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F

Table 55: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F

Table 56: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F

Table 57: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F

Table 58: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F

Table 59: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F

Table 60: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F

Table 61: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F

Table 62: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F

Table 63: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F

Table 64: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F

Ismail Sutaria
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global Drug Delivery Solutions Market Share Analysis, By Product, 2021E & 2031F

Figure 02: Global Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F 

Figure 03: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Product, 2019H-2031F

Figure 04: Global Drug Delivery Solutions Market Share Analysis, By Material, 2021E & 2031F

Figure 05: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F

Figure 06: Global Drug Delivery Solutions Market Attractiveness Analysis, By Material, 2021E-2031F

Figure 07: Global Drug Delivery Solutions Market Share Analysis, By Applications, 2021E & 2031F

Figure 08: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Applications, 2019H-2031F

Figure 09: Global Drug Delivery Solutions Market Attractiveness Analysis, By Applications, 2021E-2031F

Figure 10: Global Drug Delivery Solutions Market Share Analysis, By Region 2021E & 2031F

Figure 11: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Region, 2019H-2031F

Figure 12: Global Drug Delivery Solutions Market Attractiveness Analysis, By Region, 2021E-2031F

Figure 13: North America Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F 

Figure 14: North America Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F

Figure 15: North America Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)

Figure 16: North America Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F

Figure 17: Latin America Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F 

Figure 18: Latin America Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F

Figure 19: Latin America Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)

Figure 20: Latin America Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F

Figure 21: Europe Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F 

Figure 22: Europe Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F

Figure 23: Europe Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)

Figure 24: Europe Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F

Figure 25: South Asia Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F 

Figure 26: South Asia Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F

Figure 27: South Asia Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)

Figure 28: South Asia Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F

Figure 29: East Asia Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F 

Figure 30: East Asia Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F

Figure 31: East Asia Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)

Figure 32: East Asia Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F

Figure 33: Oceania Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F 

Figure 34: Oceania Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F

Figure 35: Oceania Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)

Figure 36: Oceania Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F

Figure 37: Middle East and Africa Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F 

Figure 38: Middle East and Africa Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F

Figure 39: Middle East and Africa Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E)

Figure 40: Middle East and Africa Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F

Figure 41: U.S. Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 42: U.S. Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 43: U.S. Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 44: Canada Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 45: Canada Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 46: Canada Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 47: Brazil Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 48: Brazil Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 49: Brazil Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 50: Mexico Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 51: Mexico Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 52: Mexico Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 53: Germany Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 54: Germany Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 55: Germany Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 56: Italy Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 57: Italy Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 58: Italy Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 59: France Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 60: France Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 61: France Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 62: U.K. Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 63: U.K. Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 64: U.K. Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 65: Spain Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 66: Spain Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 67: Spain Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 68: Russia Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 69: Russia Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 70: Russia Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 71: GCC Countries Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 72: GCC Countries Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 73: GCC Countries Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 74: China Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 75: China Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 76: China Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 77: Japan Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 78: Japan Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 79: Japan Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 80: India Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 81: India Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 82: India Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Figure 83: Australia Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F)

Figure 84: Australia Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F)

Figure 85: Australia Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)

Need specific information?

Request Customization

Explore Packaging Insights

View Reports

Recommendations

Packaging

Rigid Packaging Containers Market

Published : July 2020

Packaging

Pharmaceutical Packaging Market

Published : May 2021

Packaging

Anti-counterfeit Pharmaceutical Packaging Market

Published : February 2022

Packaging

Plastic Healthcare Packaging Market

Published : June 2021

Google translate

Drug Delivery Solutions Market